Selvakumar Elangovan

Employment

• Kalinga Institute of Industrial Technology Associate Professor
  2019 - Present
• Kalinga Institute of Industrial Technology Assistant Professor
  2012 - 2019
• Georgia Regents University Medical College of Georgia Postdoctoral Fellow
  2008 - 2012
• New York Medical College Postdoctoral Fellow
  2006 - 2008

Education

• University of Madras - Taramani Campus PhD
  2002 - 2006
• University of Madras - Taramani Campus MSc
  2000 - 2002
• University of Madras BSc Biochemistry
  1997 - 2000

Projects & Funding

Projects & funding information is unavailable.

Publications (45)

• Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers
  Biomedicines 2025 DOI: 10.3390/biomedicines13010173
  +Save
• Investigating the Role of SPP1 (Osteopontin) in the Progression of Breast and other Cancers
  2024 DOI: 10.20944/preprints202410.1898.v1
  +Save
• Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells
  Medical Oncology 2024 DOI: 10.1007/s12032-024-02329-1
  +Save
• Estrogen-Related Receptor Alpha (ERRα) Promotes Cancer Stem Cell-Like Characteristics in Breast Cancer
  Stem Cell Reviews and Reports 2023 DOI: 10.1007/s12015-023-10605-2
  +Save
• Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy
  Medical Oncology 2023 DOI: 10.1007/s12032-023-02193-5
  +Save
• Redefining Lobe-Wise Ground-Glass Opacity in COVID-19 Through Deep Learning and its Correlation With Biochemical Parameters
  IEEE Journal of Biomedical and Health Informatics 2023 DOI: 10.1109/jbhi.2023.3263431
  +Save
• Unravelling the Evolutionary Dynamics of High-Risk Klebsiella pneumoniae ST147 Clones: Insights from Comparative Pangenome Analysis
  Genes 2023 DOI: 10.3390/genes14051037
  +Save
• Plasmodium falciparum HSP40 protein eCiJp traffics to the erythrocyte cytoskeleton and interacts with the human HSP70 chaperone HSPA1
  FEBS Letters 2022 DOI: 10.1002/1873-3468.14255
  +Save
• Novel Levilactobacillus brevis-based formulation for controlling cell proliferation, cell migration and gut dysbiosis
  LWT 2022 DOI: 10.1016/j.lwt.2021.112818
  +Save
• Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA
  Molecular and Cellular Biochemistry 2021 DOI: 10.1007/s11010-021-04249-4
  +Save